Europe Point-Of-Care-Testing (POCT), By Device Type (Handheld And Bench Top), Product (Cardio-Metabolic Monitoring, Glucose Monitoring, Fertility And Pregnancy, Coagulation Monitoring, Infectious Disease, Hematology, Tumor Marker, Urinalysis Testing, Cholesterol Test, Drug Abuse Testing, Fecal Occult Testing And Others), Diseases (Cardiology, Diabetes, Gynecology, Respiratory Diseases, Liver Diseases And Others), Prescription Mode (Over The Counter And Prescription Based), End User (Laboratories, Diagnostic Centers, Hospitals, Home Care Settings, Clinics And Ambulance Service), Country (Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland and Rest of Europe) Industry Trends and Forecast to 2028.
The point-of-care-testing (POCT) market is expected to witness market growth at a rate of 10.00% in the forecast period of 2021 to 2028. Data Bridge Market Research report on Point-Of-Care-Testing (POCT) market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in healthcare sector globally is escalating the growth of Point-Of-Care-Testing (POCT) market.
Point-of-care testing (POCT) refers to the type of testing of samples taken from a patient and performed at or near the bedside. The results lead to possible changes in the care of that individual. POCT is defined as a diagnostic test which is conducted close to the site where clinical care needs to be delivered. The testing is often accomplished through the use portable, light and handheld instruments. It is considered an alternative to central or core laboratory testing.
The increase in prevalence of infectious diseases across the region acts as one of the major factors driving the growth of Point-Of-Care-Testing (POCT) market.
The adoption of speedy and accurate testing technology in emergency department (ED), and rise in demand for point of care testing devices for enhancing operational efficiency and patient outcomes accelerate the market growth. The rise in prevalence for cardiovascular disorders and chronic diseases among population, and surge in number of CLIA-waived POC tests further influence the market. Additionally, development in the healthcare infrastructure, rise in venture capital investments, surge in healthcare expenditure, increase in population and supportive government policies positively affects the Point-Of-Care-Testing (POCT) market. Furthermore, increase in demand for POC tests with multiplexing capabilities and healthcare decentralization extend profitable opportunity to the market players in the forecast period of 2021 to 2028.
On the other hand, lack of alignment with definitive central lab methods and stringent regulatory policies are expected to obstruct the market growth. Inadequate adoption of POC devices in professional settings and pricing pressure owing to reimbursement cuts and budget constraints are projected to challenge the Point-Of-Care-Testing (POCT) market in the forecast period of 2021-2028.
This Point-Of-Care-Testing (POCT) market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Point-Of-Care-Testing (POCT) market Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Europe Point-Of-Care-Testing (POCT) Market Scope and Market Size
The point-of-care-testing (POCT) market is segmented on the basis of device type, product, diseases, prescription mode and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of devices, the Point-Of-Care-Testing (POCT) market is segmented into handheld and bench top devices.
- On the basis of product, the Point-Of-Care-Testing (POCT) market is segmented into cardio-metabolic monitoring, glucose monitoring, fertility and pregnancy, coagulation monitoring, infectious disease, hematology, tumor marker, urinalysis testing, cholesterol test, drug abuse testing, fecal occult testing and others.
- On the basis of diseases, the Point-Of-Care-Testing (POCT) market is segmented into cardiology, diabetes, gynecology, respiratory diseases, liver diseases and others.
- On the basis of prescription mode, the Point-Of-Care-Testing (POCT) market is segmented into over the counter and prescription based.
- On the basis of end user, the Point-Of-Care-Testing (POCT) market is segmented laboratories, diagnostic centers, hospitals, home care settings, clinics and ambulance service.
Europe Point-Of-Care-Testing (POCT) Market Country Level Analysis
The point-of-care-testing (POCT) market is segmented on the basis of device type, product, diseases, prescription mode and end user.
The countries covered in the Europe point-of-care-testing (POCT) market report are Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland and Rest of Europe.
Germany dominates the Europe point-of-care-testing (POCT) market due to the technological advancements in the region. France is expected to witness high growth during the forecast period of 2021 to 2028 because of the surge in healthcare reimbursements.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Europe point-of-care-testing (POCT) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Europe Point-Of-Care-Testing (POCT) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Europe Point-Of-Care-Testing (POCT) market. The data is available for historic period 2010-2019.
Competitive Landscape and Europe Point-Of-Care-Testing (POCT) Market Share Analysis
The point-of-care-testing (POCT) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Point-Of-Care-Testing (POCT) market.
The major players covered in the Point-Of-Care-Testing (POCT) market report are F. Hoffmann-La Roche Ltd., Siemens, Holigic Inc. Abaxis, Acon Laboratories, Inc., Randox Laboratories, Ltd., Danaher, Abott, Thermo Fisher Scientific, Inc., Trivitron Healthcare, Cavidi, Clarity Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Becton, Dickinson and Company, Nova Biomedical, Trinity Biotech, Chembio Diagnostic Systems, Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., Biomérieux SA., and others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Europe Point-Of-Care-Testing (POCT) Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.